Salgia, R., Weaver, R. W., McCleod, M., Stille, J. R., Yan, S. B., Roberson, S., . . . Spigel, D. R. (2017). Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: Exploratory analysis of a phase II study. Invest New Drugs.
Citação norma ChicagoSalgia, Ravi, et al. "Prognostic and Predictive Value of Circulating Tumor Cells and CXCR4 Expression As Biomarkers for a CXCR4 Peptide Antagonist in Combination With Carboplatin-etoposide in Small Cell Lung Cancer: Exploratory Analysis of a Phase II Study." Invest New Drugs 2017.
Citação norma MLASalgia, Ravi, et al. "Prognostic and Predictive Value of Circulating Tumor Cells and CXCR4 Expression As Biomarkers for a CXCR4 Peptide Antagonist in Combination With Carboplatin-etoposide in Small Cell Lung Cancer: Exploratory Analysis of a Phase II Study." Invest New Drugs 2017.